首页> 美国卫生研究院文献>PLoS Clinical Trials >Anti-Tumor Effect against Human Cancer Xenografts by a Fully Human Monoclonal Antibody to a Variant 8-Epitope of CD44R1 Expressed on Cancer Stem Cells
【2h】

Anti-Tumor Effect against Human Cancer Xenografts by a Fully Human Monoclonal Antibody to a Variant 8-Epitope of CD44R1 Expressed on Cancer Stem Cells

机译:对人干细胞表达的CD44R1变体8-表位的完整人类单克隆抗体对人癌症异种移植物的抗肿瘤作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCD44 is a major cellular receptor for hyaluronic acids. The stem structure of CD44 encoded by ten normal exons can be enlarged by ten variant exons (v1-v10) by alternative splicing. We have succeeded in preparing MV5 fully human IgM and its class-switched GV5 IgG monoclonal antibody (mAb) recognizing the extracellular domain of a CD44R1 isoform that contains the inserted region coded by variant (v8, v9 and v10) exons and is expressed on the surface of various human epithelial cancer cells.
机译:背景CD44是透明质酸的主要细胞受体。通过交替剪接,由十个正常外显子编码的CD44的茎结构可以被十个变异外显子(v1-v10)扩大。我们已经成功制备了MV5完全人类IgM及其类别转换的GV5 IgG单克隆抗体(mAb),可识别CD44R1亚型的胞外域,该域包含由变异体(v8,v9和v10)外显子编码的插入区,并在各种人类上皮癌细胞的表面。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号